How To Safely Handle Your Antibody Drug Conjugate
Source: Lonza
Antibody Drug Conjugates (ADCs) have a highly specific mechanism of action which is an advantage for the treatment of several oncology indications. They are made of a highly toxic payload, a linker, and an antibody. Usually, they are classified as Highly Potent APIs (HPAPIs) compounds due to the payload.
Handling and manufacturing can be challenging due to the strict requirements for containment. With the help of internal specialized occupational toxicology and industrial hygiene knowledge, we can support the growing business to solve the mystery of safe handling ADCs.
Key Learning Objectives:
- Definition of Antibody Drug Conjugates ADCs
- Toxicological assessment of ADCs
- Assessing the risk of exposure and defining the containment for ADCs
- Occupational Hygiene Monitoring of ADCs
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
This website uses cookies to ensure you get the best experience on our website. Learn more